WallStreetZenWallStreetZen

NASDAQ: EPIX
Essa Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EPIX

Based on 1 analyst offering 12 month price targets for Essa Pharma Inc

Min Forecast
$2.00+13.64%
Avg Forecast
$2.00+13.64%
Max Forecast
$2.00+13.64%

Should I buy or sell EPIX stock?

Based on 1 analyst offering ratings for Essa Pharma Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their EPIX stock forecasts and price targets.

EPIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-04

1 of 1

Forecast return on equity

Is EPIX forecast to generate an efficient return?

Company
62.94%
Industry
241.5%
Market
68.23%
EPIX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EPIX forecast to generate an efficient return on assets?

Company
61.21%
Industry
35.8%
EPIX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EPIX earnings per share forecast

What is EPIX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.41
Avg 2 year Forecast
-$0.16
Avg 3 year Forecast
$0.79

EPIX revenue forecast

What is EPIX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$22.3M
Avg 2 year Forecast
$174.4M
Avg 3 year Forecast
$201.5M

EPIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EPIX$1.76$2.00+13.64%Hold
AVTX$7.54$32.00+324.40%Strong Buy
ARMP$2.15$7.00+225.58%Buy
AADI$3.14$1.75-44.27%Hold
THTX$1.72N/AN/A
View Top Biotech Stocks

Essa Pharma Stock Forecast FAQ

Is Essa Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EPIX) stock is to Hold EPIX stock.

Out of 1 analyst, 0 (0%) are recommending EPIX as a Strong Buy, 0 (0%) are recommending EPIX as a Buy, 1 (100%) are recommending EPIX as a Hold, 0 (0%) are recommending EPIX as a Sell, and 0 (0%) are recommending EPIX as a Strong Sell.

If you're new to stock investing, here's how to buy Essa Pharma stock.

What is EPIX's earnings growth forecast for 2025-2027?

(NASDAQ: EPIX) Essa Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.9%.

Essa Pharma's earnings in 2025 is -$28,542,821.On average, 3 Wall Street analysts forecast EPIX's earnings for 2025 to be -$18,345,788, with the lowest EPIX earnings forecast at -$26,189,245, and the highest EPIX earnings forecast at -$13,760,451. On average, 3 Wall Street analysts forecast EPIX's earnings for 2026 to be -$7,248,650, with the lowest EPIX earnings forecast at -$21,750,390, and the highest EPIX earnings forecast at $7,102,168.

In 2027, EPIX is forecast to generate $35,213,437 in earnings, with the lowest earnings forecast at -$21,750,390 and the highest earnings forecast at $134,497,307.

What is EPIX's revenue growth forecast for 2026-2028?

(NASDAQ: EPIX) Essa Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.63%.

Essa Pharma's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast EPIX's revenue for 2026 to be $988,533,009, with the lowest EPIX revenue forecast at $988,533,009, and the highest EPIX revenue forecast at $988,533,009. On average, 1 Wall Street analysts forecast EPIX's revenue for 2027 to be $7,740,919,235, with the lowest EPIX revenue forecast at $7,740,919,235, and the highest EPIX revenue forecast at $7,740,919,235.

In 2028, EPIX is forecast to generate $8,942,961,169 in revenue, with the lowest revenue forecast at $2,800,029,734 and the highest revenue forecast at $15,085,892,603.

What is EPIX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: EPIX) forecast ROA is 61.21%, which is higher than the forecast US Biotechnology industry average of 35.8%.

What is EPIX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EPIX price target, the average EPIX price target is $2.00, with the highest EPIX stock price forecast at $2.00 and the lowest EPIX stock price forecast at $2.00.

The Wall Street analyst predicted that Essa Pharma's share price could reach $2.00 by Nov 4, 2025. The average Essa Pharma stock price prediction forecasts a potential upside of 13.64% from the current EPIX share price of $1.76.

What is EPIX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: EPIX) Essa Pharma's current Earnings Per Share (EPS) is -$0.64. On average, analysts forecast that EPIX's EPS will be -$0.41 for 2025, with the lowest EPS forecast at -$0.59, and the highest EPS forecast at -$0.31. On average, analysts forecast that EPIX's EPS will be -$0.16 for 2026, with the lowest EPS forecast at -$0.49, and the highest EPS forecast at $0.16. In 2027, EPIX's EPS is forecast to hit $0.79 (min: -$0.49, max: $3.03).

What is EPIX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: EPIX) forecast ROE is 62.94%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.